Zhejiang Huahai Pharmaceutical Co Ltd (600521) — Cash Flow Quality Index
Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Cash Flow Quality Index of 1.56x as of June 2025. Operating cash flow of CN¥174.53 Million exceeds net income of CN¥112.08 Million, indicating high earnings quality where cash backs reported profits. Explore Zhejiang Huahai Pharmaceutical Co Ltd (600521) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow Quality Index (2001–2025)
Historical Cash Flow Quality Index for Zhejiang Huahai Pharmaceutical Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Zhejiang Huahai Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Year-by-year earnings quality comparison for Zhejiang Huahai Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Zhejiang Huahai Pharmaceutical Co Ltd stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.62x | CN¥1.23 Billion | CN¥266.40 Million | ▲ +135.4% |
| 2024 | 1.96x | CN¥2.17 Billion | CN¥1.11 Billion | ▼ -26.5% |
| 2023 | 2.67x | CN¥2.22 Billion | CN¥830.47 Million | ▲ +152.6% |
| 2022 | 1.06x | CN¥1.24 Billion | CN¥1.18 Billion | ▼ -45.9% |
| 2021 | 1.95x | CN¥938.43 Million | CN¥480.64 Million | ▲ +24.8% |
| 2020 | 1.56x | CN¥1.56 Billion | CN¥994.60 Million | ▼ -45.9% |
| 2019 | 2.89x | CN¥1.75 Billion | CN¥606.83 Million | ▲ +474.3% |
| 2018 | 0.50x | CN¥67.90 Million | CN¥134.90 Million | ▼ -42.5% |
| 2017 | 0.88x | CN¥546.24 Million | CN¥623.59 Million | ▼ -7.6% |
| 2016 | 0.95x | CN¥433.10 Million | CN¥456.90 Million | ▲ +112.0% |
| 2015 | 0.45x | CN¥195.31 Million | CN¥436.72 Million | ▼ -65.1% |
| 2014 | 1.28x | CN¥328.61 Million | CN¥256.73 Million | ▼ -5.1% |
| 2013 | 1.35x | CN¥490.29 Million | CN¥363.42 Million | ▲ +87.3% |
| 2012 | 0.72x | CN¥243.83 Million | CN¥338.49 Million | ▼ -21.9% |
| 2011 | 0.92x | CN¥197.51 Million | CN¥214.09 Million | ▼ -71.2% |
| 2010 | 3.20x | CN¥299.47 Million | CN¥93.53 Million | ▲ +65.8% |
| 2009 | 1.93x | CN¥317.44 Million | CN¥164.39 Million | ▲ +243.7% |
| 2008 | 0.56x | CN¥84.20 Million | CN¥149.86 Million | ▼ -45.7% |
| 2007 | 1.03x | CN¥136.52 Million | CN¥132.05 Million | ▲ +46.8% |
| 2006 | 0.70x | CN¥77.54 Million | CN¥110.07 Million | ▲ +70.5% |
| 2005 | 0.41x | CN¥53.30 Million | CN¥128.99 Million | ▼ -69.9% |
| 2004 | 1.37x | CN¥163.73 Million | CN¥119.13 Million | ▲ +129.9% |
| 2003 | 0.60x | CN¥47.41 Million | CN¥79.29 Million | ▼ -59.8% |
| 2002 | 1.49x | CN¥75.34 Million | CN¥50.61 Million | ▲ +69.6% |
| 2001 | 0.88x | CN¥37.51 Million | CN¥42.72 Million | — |